Your browser doesn't support javascript.
loading
Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable Pseudomonas Aeruginosa Strains via Mechanism-Based Modelling.
Rees, Vanessa E; Bulitta, Jürgen B; Oliver, Antonio; Nation, Roger L; Landersdorfer, Cornelia B.
Afiliación
  • Rees VE; Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville campus), Parkville, VIC 3052, Australia. roger.nation@monash.edu.
  • Bulitta JB; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville campus), Parkville, VIC 3052, Australia. roger.nation@monash.edu.
  • Oliver A; The Novo Nordisk Centre for Biosustainability, The Technical University of Denmark (DTU), 2800 Kgs. Lyngby, Denmark. roger.nation@monash.edu.
  • Nation RL; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Orlando, FL 32827, USA. jbulitta@cop.ufl.edu.
  • Landersdorfer CB; Servicio de Microbiología, Hospital Universitario Son Espases, Instituto de Investigación Sanitaria de Palma, 07120 Palma de Mallorca, Spain. antonio.oliver@ssib.es.
Pharmaceutics ; 11(9)2019 Sep 12.
Article en En | MEDLINE | ID: mdl-31547301
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2019 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2019 Tipo del documento: Article País de afiliación: Australia